| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_266f27c9e90e00b1173c45726524c540 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-22 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-22 |
| filingDate |
2006-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cbf26f5b36ae60a7e161f363c77467b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc4a22856e3177ee7795a1de49ab210c |
| publicationDate |
2008-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20080059244-A |
| titleOfInvention |
New Crystalline Forms of Irinotecan Hydrochloride |
| abstract |
The present invention provides novel crystalline forms of irinotecan hydrochloride and methods for their preparation, pharmaceutical compositions containing these new crystalline forms and methods for treating metastatic carcinoma of the colon or rectum. |
| priorityDate |
2005-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |